Media Database
>
Hannah Kuchler

Hannah Kuchler

Global Pharma Editor / Global Pharmaceuticals Correspondent at Financial Times

Contact this person
Email address
i*****@*******.comGet email address
Influence score
53
Phone
(XXX) XXX-XXXX Get mobile number
Location
United Kingdom
Languages
  • English
Covering topics
  • Health & Medicine

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

ft.com

NHS signs deal with Scancell in ambitious skin cancer trial

Move comes as government seeks to boost UK’s standing as drugs research leader
ft.com

Swiss drugmaker Novartis to invest $23bn in US manufacturing and R&D

Pharma group builds out American supply chains as part of preparations for potential US tariffs
ft.com

UK promises rapid review of NHS drug-pricing rebate

Under the scheme, drugmakers discount price of medicines sold in bulk to healthcare system
ft.com

Former UK IPO star Nanopore admits it is a takeover target

DNA sequencing specialist’s decision to list in London in 2021 was seen as a victory for the market at the time
ft.com

Higher medicine sales tax makes UK ‘uninvestable’, warn drugmakers

Industry lobby group calls for action from government ahead of summit in April
ft.com

Hikma races to launch generic versions of blockbuster obesity drugs

Pharma group looks to take advantage as Wegovy and Ozempic start to go off patent next year
ft.com

Drugmakers prepare to sue EU over tax to pay for wastewater clean-up

Pharma and cosmetics industries want other sectors to contribute ‘fair share’ towards cost of removing pollutants
ft.com

AstraZeneca hit with US class action lawsuit over China regulatory ...

Lawsuit claims UK pharma giant understated the risk of government investigations
ft.com

Biotech behind Alzheimer’s drug seeks partners for blood-brain barr...

BioArctic is developing a process to allow drugs to cross the layer of cells that protects the brain
ft.com

Novartis agrees $3bn deal to buy heart drug biotech from Blackstone

Anthos Therapeutics was set up by Blackstone Life Sciences after it licensed abelacimab drug from Novartis in 2019
ft.com

GSK launches £2bn buyback on strong HIV and cancer drugs sales

UK pharma group raises long-term annual sales forecast to more than £40bn by 2031